Form 4 for ZTS Zoetis
Accepted 2023-04-19 00:00:00 ET · period of report 2023-04-18 · accession 0001555280-23-000140 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-04-19 | 2023-04-18 | ZTS | Lagano Roxanne | EVP | M - OptEx | $79.85 | +4,338 | 30.7K | +16% | +$346.4K |
| D | 2023-04-19 | 2023-04-18 | ZTS | Lagano Roxanne | EVP | S - Sale+OE | $175.94 | -4,338 | 26.4K | -14% | -$763.2K |
| DM | 2023-04-19 | 2023-04-18 | ZTS | Lagano Roxanne | EVP | M - OptEx | $0.00 | -4,338 | 22.2K | -16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-18 | M | A | 2,328 | $73.24 | 28,685 | D | — | — | |
| 2 | Common | Common Stock | 2023-04-18 | M | A | 2,010 | $87.51 | 30,695 | D | — | — | |
| 3 | Common | Common Stock | 2023-04-18 | S | D | 4,338 | $175.94 | 26,357 | D | — | — | (F2) The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. |
| 4 | Derivative | Stock Option | 2023-04-18 | M | D | 2,010 | $0.00 | 20,221 | D | — · — to — | 2,010 Common Stock | (F4) Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. (F10) 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option. (F9) 2,010 options granted on February 12, 2019 at an exercise price of $87.51 per option. (F6) Each option vests on the third anniversary of the date of grant. (F7) Each option expires on the tenth anniversary of the date of grant. |
| 5 | Derivative | Stock Option | 2023-04-18 | M | D | 2,328 | $0.00 | 22,231 | D | — · — to — | 2,328 Common Stock | (F4) Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. (F8) 2,010 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option. (F5) 2,328 options granted February 13, 2018 at an exercise price of $73.24 per option. (F6) Each option vests on the third anniversary of the date of grant. (F7) Each option expires on the tenth anniversary of the date of grant. |